An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe.
Denis Horgan, Marleen Jansen, Lada Leyens, Jonathan A Lal, Ralf Sudbrak, Erica Hackenitz, Ulrike Bußhoff, Wolfgang Ballensiefen, Angela Brand. Public Health Genomics 2014
Times Cited: 41
Times Cited: 41
Times Cited
Times Co-cited
Similarity
Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective.
Lada Leyens, Denis Horgan, Jonathan A Lal, Kirsten Steinhausen, Kapaettu Satyamoorthy, Angela Brand. Per Med 2014
Lada Leyens, Denis Horgan, Jonathan A Lal, Kirsten Steinhausen, Kapaettu Satyamoorthy, Angela Brand. Per Med 2014
71
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
12
Implementation and utilization of genetic testing in personalized medicine.
Noura S Abul-Husn, Aniwaa Owusu Obeng, Saskia C Sanderson, Omri Gottesman, Stuart A Scott. Pharmgenomics Pers Med 2014
Noura S Abul-Husn, Aniwaa Owusu Obeng, Saskia C Sanderson, Omri Gottesman, Stuart A Scott. Pharmgenomics Pers Med 2014
9
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.
A R Shuldiner, M V Relling, J F Peterson, J K Hicks, R R Freimuth, W Sadee, N L Pereira, D M Roden, J A Johnson, T E Klein,[...]. Clin Pharmacol Ther 2013
A R Shuldiner, M V Relling, J F Peterson, J K Hicks, R R Freimuth, W Sadee, N L Pereira, D M Roden, J A Johnson, T E Klein,[...]. Clin Pharmacol Ther 2013
9
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
9
9
9
Virtual Clinical Trials, an Essential Step in Increasing the Effectiveness of the Drug Development Process.
Hans Lehrach. Public Health Genomics 2015
Hans Lehrach. Public Health Genomics 2015
44
Evidence based medicine: what it is and what it isn't.
D L Sackett, W M Rosenberg, J A Gray, R B Haynes, W S Richardson. BMJ 1996
D L Sackett, W M Rosenberg, J A Gray, R B Haynes, W S Richardson. BMJ 1996
9
Is precision medicine the route to a healthy world?
Denis Horgan, Angelo Paradiso, Gordon McVie, Ian Banks, Tom Van der Wal, Angela Brand, Mark Lawler. Lancet 2015
Denis Horgan, Angelo Paradiso, Gordon McVie, Ian Banks, Tom Van der Wal, Angela Brand, Mark Lawler. Lancet 2015
33
Implementing genomic medicine in the clinic: the future is here.
Teri A Manolio, Rex L Chisholm, Brad Ozenberger, Dan M Roden, Marc S Williams, Richard Wilson, David Bick, Erwin P Bottinger, Murray H Brilliant, Charis Eng,[...]. Genet Med 2013
Teri A Manolio, Rex L Chisholm, Brad Ozenberger, Dan M Roden, Marc S Williams, Richard Wilson, David Bick, Erwin P Bottinger, Murray H Brilliant, Charis Eng,[...]. Genet Med 2013
9
Pharmacogenomic information in drug labels: European Medicines Agency perspective.
F Ehmann, L Caneva, K Prasad, M Paulmichl, M Maliepaard, A Llerena, M Ingelman-Sundberg, M Papaluca-Amati. Pharmacogenomics J 2015
F Ehmann, L Caneva, K Prasad, M Paulmichl, M Maliepaard, A Llerena, M Ingelman-Sundberg, M Papaluca-Amati. Pharmacogenomics J 2015
9
Personalised medicine: the cognitive side of patients.
Ilaria Cutica, Gordon Mc Vie, Gabriella Pravettoni. Eur J Intern Med 2014
Ilaria Cutica, Gordon Mc Vie, Gabriella Pravettoni. Eur J Intern Med 2014
11
Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
7
Pharmacogenetics in Europe: barriers and opportunities.
D Gurwitz, E Zika, M M Hopkins, S Gaisser, D Ibarreta. Public Health Genomics 2009
D Gurwitz, E Zika, M M Hopkins, S Gaisser, D Ibarreta. Public Health Genomics 2009
8
Ask not what personalized medicine can do for you--ask what you can do for personalized medicine.
Isabelle Budin-Ljøsne, Jennifer R Harris. Public Health Genomics 2015
Isabelle Budin-Ljøsne, Jennifer R Harris. Public Health Genomics 2015
25
Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU).
Kristine Sørensen, Jürgen M Pelikan, Florian Röthlin, Kristin Ganahl, Zofia Slonska, Gerardine Doyle, James Fullam, Barbara Kondilis, Demosthenes Agrafiotis, Ellen Uiters,[...]. Eur J Public Health 2015
Kristine Sørensen, Jürgen M Pelikan, Florian Röthlin, Kristin Ganahl, Zofia Slonska, Gerardine Doyle, James Fullam, Barbara Kondilis, Demosthenes Agrafiotis, Ellen Uiters,[...]. Eur J Public Health 2015
7
A tiered-layered-staged model for informed consent in personal genome testing.
Eline M Bunnik, A Cecile J W Janssens, Maartje H N Schermer. Eur J Hum Genet 2013
Eline M Bunnik, A Cecile J W Janssens, Maartje H N Schermer. Eur J Hum Genet 2013
7
Early Patient Access to Medicines: Health Technology Assessment Bodies Need to Catch Up with New Marketing Authorization Methods.
Lada Leyens, Angela Brand. Public Health Genomics 2016
Lada Leyens, Angela Brand. Public Health Genomics 2016
21
What is personalized medicine: sharpening a vague term based on a systematic literature review.
Sebastian Schleidgen, Corinna Klingler, Teresa Bertram, Wolf H Rogowski, Georg Marckmann. BMC Med Ethics 2013
Sebastian Schleidgen, Corinna Klingler, Teresa Bertram, Wolf H Rogowski, Georg Marckmann. BMC Med Ethics 2013
7
Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumab.
C Leopold, S Vogler, C Habl, A K Mantel-Teeuwisse, J Espin. Health Policy 2013
C Leopold, S Vogler, C Habl, A K Mantel-Teeuwisse, J Espin. Health Policy 2013
17
How many molecular subtypes? Implications of the unique tumor principle in personalized medicine.
Shuji Ogino, Charles S Fuchs, Edward Giovannucci. Expert Rev Mol Diagn 2012
Shuji Ogino, Charles S Fuchs, Edward Giovannucci. Expert Rev Mol Diagn 2012
7
A revolution in healthcare: challenges and opportunities for personalized medicine.
Hans Lehrach. Per Med 2012
Hans Lehrach. Per Med 2012
75
European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine.
Sebastian Schee Genannt Halfmann, Nikolaos Evangelatos, Peter Schröder-Bäck, Angela Brand. Per Med 2017
Sebastian Schee Genannt Halfmann, Nikolaos Evangelatos, Peter Schröder-Bäck, Angela Brand. Per Med 2017
60
Barriers for integrating personalized medicine into clinical practice: a qualitative analysis.
Mehdi Najafzadeh, Jennifer C Davis, Pamela Joshi, Carlo Marra. Am J Med Genet A 2013
Mehdi Najafzadeh, Jennifer C Davis, Pamela Joshi, Carlo Marra. Am J Med Genet A 2013
17
The theory of reference values: an unfinished symphony.
Gerard Siest, Joseph Henny, Ralph Gräsbeck, Peter Wilding, Claude Petitclerc, Josep M Queraltó, Peter Hyltoft Petersen. Clin Chem Lab Med 2013
Gerard Siest, Joseph Henny, Ralph Gräsbeck, Peter Wilding, Claude Petitclerc, Josep M Queraltó, Peter Hyltoft Petersen. Clin Chem Lab Med 2013
4
Whole genome sequencing as a diagnostic test: challenges and opportunities.
Caitlin C Chrystoja, Eleftherios P Diamandis. Clin Chem 2014
Caitlin C Chrystoja, Eleftherios P Diamandis. Clin Chem 2014
4
Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists.
Taku Obara, Shinya Abe, Michihiro Satoh, Sergio Ramón Gutiérrez Ubeda, Shoko Yoshimachi, Teruaki Goto. Pharmgenomics Pers Med 2015
Taku Obara, Shinya Abe, Michihiro Satoh, Sergio Ramón Gutiérrez Ubeda, Shoko Yoshimachi, Teruaki Goto. Pharmgenomics Pers Med 2015
33
Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.
Minhaz Uddin Ahmed, Ishtiaq Saaem, Pae C Wu, April S Brown. Crit Rev Biotechnol 2014
Minhaz Uddin Ahmed, Ishtiaq Saaem, Pae C Wu, April S Brown. Crit Rev Biotechnol 2014
4
miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?
Emeline Goretti, Daniel R Wagner, Yvan Devaux. Trends Mol Med 2014
Emeline Goretti, Daniel R Wagner, Yvan Devaux. Trends Mol Med 2014
4
Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).
F Ciardiello, D Arnold, P G Casali, A Cervantes, J-Y Douillard, A Eggermont, A Eniu, K McGregor, S Peters, M Piccart,[...]. Ann Oncol 2014
F Ciardiello, D Arnold, P G Casali, A Cervantes, J-Y Douillard, A Eggermont, A Eniu, K McGregor, S Peters, M Piccart,[...]. Ann Oncol 2014
4
Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation.
James S Hernandez, Jane C Dale, Kevin E Bennet, Prathibha Varkey. Am J Clin Pathol 2010
James S Hernandez, Jane C Dale, Kevin E Bennet, Prathibha Varkey. Am J Clin Pathol 2010
28
Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999.
Payman Shahabi, Gérard Siest, Bernard Herbeth, Ndeye Coumba Ndiaye, Sophie Visvikis-Siest. Clin Chim Acta 2012
Payman Shahabi, Gérard Siest, Bernard Herbeth, Ndeye Coumba Ndiaye, Sophie Visvikis-Siest. Clin Chim Acta 2012
18
Laboratory medicine: challenges and opportunities.
Xavier Bossuyt, Kurt Verweire, Norbert Blanckaert. Clin Chem 2007
Xavier Bossuyt, Kurt Verweire, Norbert Blanckaert. Clin Chem 2007
4
Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation.
Subhash C Arya, James S Hernandez, Jane C Dale, Kevin E Bennet, Prathibha Varkey. Am J Clin Pathol 2010
Subhash C Arya, James S Hernandez, Jane C Dale, Kevin E Bennet, Prathibha Varkey. Am J Clin Pathol 2010
66
66
Personalized (laboratory) medicine: a bridge to the future.
Mario Plebani, Giuseppe Lippi. Clin Chem Lab Med 2013
Mario Plebani, Giuseppe Lippi. Clin Chem Lab Med 2013
13
Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine.
Shih-Yi Lin, Wu-Huei Hsu, Cheng-Chieh Lin, Chao-Jung Chen. Biomedicine (Taipei) 2014
Shih-Yi Lin, Wu-Huei Hsu, Cheng-Chieh Lin, Chao-Jung Chen. Biomedicine (Taipei) 2014
16
Inter-individual variation of inflammatory markers of cardiovascular risks and diseases.
Hind Berrahmoune, John Lamont, Peter Fitzgerald, Sophie Visvikis-Siest. Clin Chem Lab Med 2005
Hind Berrahmoune, John Lamont, Peter Fitzgerald, Sophie Visvikis-Siest. Clin Chem Lab Med 2005
15
Biomedical research: increasing value, reducing waste.
Malcolm R Macleod, Susan Michie, Ian Roberts, Ulrich Dirnagl, Iain Chalmers, John P A Ioannidis, Rustam Al-Shahi Salman, An-Wen Chan, Paul Glasziou. Lancet 2014
Malcolm R Macleod, Susan Michie, Ian Roberts, Ulrich Dirnagl, Iain Chalmers, John P A Ioannidis, Rustam Al-Shahi Salman, An-Wen Chan, Paul Glasziou. Lancet 2014
4
Policies to aid the adoption of personalized medicine.
Charity Nofziger, Marisa Papaluca, Andre Terzic, Scott Waldman, Markus Paulmichl. Nat Rev Drug Discov 2014
Charity Nofziger, Marisa Papaluca, Andre Terzic, Scott Waldman, Markus Paulmichl. Nat Rev Drug Discov 2014
40
Personalized medicine and the clinical laboratory.
João Renato Rebello Pinho, Roberta Sitnik, Cristóvão Luis Pitangueira Mangueira. Einstein (Sao Paulo) 2014
João Renato Rebello Pinho, Roberta Sitnik, Cristóvão Luis Pitangueira Mangueira. Einstein (Sao Paulo) 2014
50
Omics and drug response.
Urs A Meyer, Ulrich M Zanger, Matthias Schwab. Annu Rev Pharmacol Toxicol 2013
Urs A Meyer, Ulrich M Zanger, Matthias Schwab. Annu Rev Pharmacol Toxicol 2013
4
Pharmacogenomics and individualized medicine: translating science into practice.
K R Crews, J K Hicks, C-H Pui, M V Relling, W E Evans. Clin Pharmacol Ther 2012
K R Crews, J K Hicks, C-H Pui, M V Relling, W E Evans. Clin Pharmacol Ther 2012
4
Charting a course for genomic medicine from base pairs to bedside.
Eric D Green, Mark S Guyer. Nature 2011
Eric D Green, Mark S Guyer. Nature 2011
4
Clinical pharmacogenetics implementation: approaches, successes, and challenges.
Kristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, Benjamin Burkley, David R Nessl, Aniwaa Owusu Obeng, Benjamin J Staley, Hui-Jia Dong, Robert W Allan, J Felix Liu,[...]. Am J Med Genet C Semin Med Genet 2014
Kristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, Benjamin Burkley, David R Nessl, Aniwaa Owusu Obeng, Benjamin J Staley, Hui-Jia Dong, Robert W Allan, J Felix Liu,[...]. Am J Med Genet C Semin Med Genet 2014
4
Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
4
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.